176 related articles for article (PubMed ID: 28826645)
1. Oral Ketorolac for Pain Relief During Intrauterine Device Insertion: A Double-Blinded Randomized Controlled Trial.
Crawford M; Davy S; Book N; Elliott JO; Arora A
J Obstet Gynaecol Can; 2017 Dec; 39(12):1143-1149. PubMed ID: 28826645
[TBL] [Abstract][Full Text] [Related]
2. Ketorolac for Pain Control With Intrauterine Device Placement: A Randomized Controlled Trial.
Ngo LL; Ward KK; Mody SK
Obstet Gynecol; 2015 Jul; 126(1):29-36. PubMed ID: 26241253
[TBL] [Abstract][Full Text] [Related]
3. Naproxen Sodium for Pain Control With Intrauterine Device Insertion: A Randomized Controlled Trial.
Ngo LL; Braaten KP; Eichen E; Fortin J; Maurer R; Goldberg AB
Obstet Gynecol; 2016 Dec; 128(6):1306-1313. PubMed ID: 27824753
[TBL] [Abstract][Full Text] [Related]
4. Different analgesics prior to intrauterine device insertion: is there any evidence of efficacy?
Elkhouly NI; Maher MA
Eur J Contracept Reprod Health Care; 2017 Jun; 22(3):222-226. PubMed ID: 28463028
[TBL] [Abstract][Full Text] [Related]
5. Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion. A randomized, double-blinded, placebo-controlled study.
Fouda UM; Salah Eldin NM; Elsetohy KA; Tolba HA; Shaban MM; Sobh SM
Contraception; 2016 Jun; 93(6):513-8. PubMed ID: 26852833
[TBL] [Abstract][Full Text] [Related]
6. Intranasal ketorolac for pain secondary to third molar impaction surgery: a randomized, double-blind, placebo-controlled trial.
Grant GM; Mehlisch DR
J Oral Maxillofac Surg; 2010 May; 68(5):1025-31. PubMed ID: 20207062
[TBL] [Abstract][Full Text] [Related]
7. Self-Administered Lidocaine Gel for Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled Trial.
Rapkin RB; Achilles SL; Schwarz EB; Meyn L; Cremer M; Boraas CM; Chen BA
Obstet Gynecol; 2016 Sep; 128(3):621-8. PubMed ID: 27500351
[TBL] [Abstract][Full Text] [Related]
8. Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial.
Mody SK; Farala JP; Jimenez B; Nishikawa M; Ngo LL
Obstet Gynecol; 2018 Sep; 132(3):575-582. PubMed ID: 30095776
[TBL] [Abstract][Full Text] [Related]
9. Comparative Efficacy of Vaginal Misoprostol vs Vaginal Dinoprostone Administered 3 Hours Prior to Copper T380A Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled Trial.
Ashour ASA; El Sharkawy M; Ali AS; Keshta NHA; Shatat HBAE; El Mahy M
J Pediatr Adolesc Gynecol; 2020 Oct; 33(5):559-565. PubMed ID: 32330638
[TBL] [Abstract][Full Text] [Related]
10. Self-administered vaginal lidocaine gel for pain management with intrauterine device insertion: a blinded, randomized controlled trial.
Conti JA; Lerma K; Schneyer RJ; Hastings CV; Blumenthal PD; Shaw KA
Am J Obstet Gynecol; 2019 Feb; 220(2):177.e1-177.e7. PubMed ID: 30444982
[TBL] [Abstract][Full Text] [Related]
11. Effect of cervical lidocaine-prilocaine cream on pain perception during copper T380A intrauterine device insertion among parous women: A randomized double-blind controlled trial.
Abbas AM; Abdellah MS; Khalaf M; Bahloul M; Abdellah NH; Ali MK; Abdelmagied AM
Contraception; 2017 Mar; 95(3):251-256. PubMed ID: 27823944
[TBL] [Abstract][Full Text] [Related]
12. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women.
Edelman AB; Schaefer E; Olson A; Van Houten L; Bednarek P; Leclair C; Jensen JT
Contraception; 2011 Sep; 84(3):234-9. PubMed ID: 21843686
[TBL] [Abstract][Full Text] [Related]
13. Effect of topical glyceryl trinitrate cream on pain perception during intrauterine device insertion in multiparous women: A randomized double-blinded placebo-controlled study.
Abbas AM; Ragab E; Abd Ellah NH; Sabra A; Ali SS; Mohamed A; Yosef AH
J Gynecol Obstet Hum Reprod; 2019 Nov; 48(9):715-718. PubMed ID: 30898632
[TBL] [Abstract][Full Text] [Related]
14. [Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion].
Jensen HH; Blaabjerg J; Lyndrup J
Ugeskr Laeger; 1998 Nov; 160(48):6958-61. PubMed ID: 9846090
[TBL] [Abstract][Full Text] [Related]
15. Intrauterine mepivacaine instillation for pain relief during intrauterine device insertion in nulliparous women: a double-blind, randomized, controlled trial.
Envall N; Lagercrantz HG; Sunesson J; Kopp Kallner H
Contraception; 2019 Jun; 99(6):335-339. PubMed ID: 30831101
[TBL] [Abstract][Full Text] [Related]
16. Comparing parecoxib and ketorolac as preemptive analgesia in patients undergoing posterior lumbar spinal fusion: a prospective randomized double-blinded placebo-controlled trial.
Siribumrungwong K; Cheewakidakarn J; Tangtrakulwanich B; Nimmaanrat S
BMC Musculoskelet Disord; 2015 Mar; 16():59. PubMed ID: 25886746
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic vaginal dinoprostone administration six hours prior to copper-T380A intrauterine device insertion in nulliparous women: A randomized controlled trial.
Samy A; Kasem MFY; El Lithy A; Ibrahim AM; El Mahy M; Hussein AH; A-Wahab H; Hussien AH; Allah AAMA; El Din Wali AA; Soliman HH; Masoud AT; Abdou H; Hussein M; Abdella RM; Mostafa M; Zaki SS
Contraception; 2020 Mar; 101(3):162-166. PubMed ID: 31811839
[TBL] [Abstract][Full Text] [Related]
18. Ketorolac use for postoperative pain management following lumbar decompression surgery: a prospective, randomized, double-blinded, placebo-controlled trial.
Cassinelli EH; Dean CL; Garcia RM; Furey CG; Bohlman HH
Spine (Phila Pa 1976); 2008 May; 33(12):1313-7. PubMed ID: 18496342
[TBL] [Abstract][Full Text] [Related]
19. Analgesia efficacy of lidocaine transfused by a novel disposable injectable cervical dilator during intrauterine device removal procedure: A randomized clinical trial.
Wang Y; Chen Q; Liu Z; Chen Y; Zheng Y; Guo J; Zhou F; Lv N; Zhao J; Shen S; Yuan Q; Tong J
Contraception; 2024 Jul; 135():110439. PubMed ID: 38552820
[TBL] [Abstract][Full Text] [Related]
20. A randomized double blinded clinical trial to explore the clinical outcomes of vaginal isonicotinic acid hydrazide (INH) administration six hours prior to T380A intrauterine device insertion in persons delivered only by cesarean delivery.
Shady NW; Farouk HA; Sallam HF
Contraception; 2023 Apr; 120():109788. PubMed ID: 35183498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
